Previous 10 | Next 10 |
Baxter International (NYSE: BAX ) upgraded to Outperform with a $94 (12% upside) price target at Evercore ISI. Shares up 1% premarket. More news on: Baxter International Inc., Henry Schein, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, , Read more ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13 at 8 a.m. Pacific Time. The presentation and Q&A session to follow will be webcast live and may be accessed through ...
Hologic, Inc. (Nasdaq: HOLX) announced today that it has completed the previously announced divestiture of its Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, less certain cl...
Stock market euphoria may not be over yet, despite worrisome signals of a reckoning, including bullish sentiment and an extreme number of stocks trading at least 5% above their 200-day moving average. According to the latest AAII Sentiment Survey , 44.1% of respondents think stock prices wi...
Mergers Three Days in a Row We are now well over $100 billion in the last six weeks in announced M&A. Talking heads still haven’t caught on that we are witnessing a significant acceleration in acquisitions. Peugeot Fiat Chrysler (FCAU) agrees to a $50 billion dollar deal, whi...
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Despite the recent rally, biotechnology is still significantly underpriced relative...
Larry Culp is a Builder of Corporations, Not a Caretaker We've all heard the nostrum "The best defense is a good offense". The best way for General Electric (GE) to dig out of its liabilities is to change the growth profile and boost cash flow. The opportunity to gather revenue-generating ...
As we push deeper into December, small-cap stocks and mid-cap stocks could begin marching higher in line with the January effect, a period during which large cap typically lags as institutional investors use the year's fresh slate to restructure portfolios for greater returns. Although the Rus...
--Company reinforces breast health leadership with innovative new products, breakthrough Artificial Intelligence-powered platform and prestigious IMV ranking-- Hologic, Inc. (Nasdaq: HOLX) will showcase its comprehensive portfolio of breast and skeletal health products, including scre...
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Larry Robbins’ Glenview Capital Manage...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...